Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
Kamran Kadkhoda, Matthew Dee, John Simeone
doi: https://doi.org/10.1101/2022.11.21.22282591
Kamran Kadkhoda
1Immunopathology Laboratory, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA
2Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA
Matthew Dee
1Immunopathology Laboratory, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA
John Simeone
1Immunopathology Laboratory, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA
Data Availability
Available
Posted November 22, 2022.
Comparison of LIAISON QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold Plus
Kamran Kadkhoda, Matthew Dee, John Simeone
medRxiv 2022.11.21.22282591; doi: https://doi.org/10.1101/2022.11.21.22282591
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4156)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2693)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2070)
- Ophthalmology (595)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1130)
- Primary Care Research (461)
- Public and Global Health (6577)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)